CD68 and ovarian carcinoma: These results were consistent with those reported by [90], developing flexible folate-targeted and oxygen/indocyanine green-loaded lipid nanoparticles (FA-OINPs) for dual-mode imaging-guided therapy in ovarian cancer cells, which reduced VEGF and microvessel density expression as well as CD68 expression.